Literature DB >> 6331818

Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder.

H C Lou, L Henriksen, P Bruhn.   

Abstract

The neural mechanisms involved in learning disorders are largely unknown. We studied three-dimensional regional cerebral blood flow (rCBF) in 13 children with dysphasia and/or attention deficit disorder (ADD), using xenon 133 inhalation and emission computed tomography. The rCBF distribution was abnormal in both hemispheres in all patients, as compared with the mean CBF distribution of nine normal children. Regions of hypoperfusion and, by inference, low metabolic activity were predominantly seen in the periventricular white matter and in border zones between major arterial territories. In patients with dysphasia, parts of both perisylvian regions were hypoperfused, and object-naming tasks failed to produce an increased flow in relevant cortical regions. Patients with different dysphasic syndromes appeared to have different patterns of rCBF. All 11 patients with ADD had hypoperfusion in the white matter of the frontal lobes and seven also in the caudate nuclei region. Methylphenidate hydrochloride increased perfusion in the central region, including the mesencephalon and the basal ganglia, and decreased perfusion of motor and primary sensory cortical areas. The location of hypoperfused structures in cognitive disorders of childhood is consistent with a role for an early hypoxic-ischemic event in their origin.

Entities:  

Mesh:

Year:  1984        PMID: 6331818     DOI: 10.1001/archneur.1984.04050190031010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  31 in total

1.  The malpractice crisis: an attorney's viewpoint.

Authors:  S E Pegalis
Journal:  Bull N Y Acad Med       Date:  1991 Mar-Apr

2.  Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development.

Authors:  Blythe A Corbett; Laura J Constantine; Robert Hendren; David Rocke; Sally Ozonoff
Journal:  Psychiatry Res       Date:  2009-03-12       Impact factor: 3.222

3.  A pattern of test findings predicting attention problems at school.

Authors:  M Korkman; K Peltomaa
Journal:  J Abnorm Child Psychol       Date:  1991-08

Review 4.  Piracetam in developmental reading disorders: A review.

Authors:  Colin R Wilsher; Eric A Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-04       Impact factor: 4.785

Review 5.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

6.  Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment.

Authors:  Jae Sung Lee; Boong Nyun Kim; Eunjoo Kang; Dong Soo Lee; Yu Kyeong Kim; June-Key Chung; Myung Chul Lee; Soo Churl Cho
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

7.  Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

Authors:  Jaswinder K Ghuman; Harinder S Ghuman
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

8.  Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.

Authors:  Danielle C Turner; Andrew D Blackwell; Jonathan H Dowson; Andrew McLean; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.

Authors:  C J Vaidya; G Austin; G Kirkorian; H W Ridlehuber; J E Desmond; G H Glover; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Neuropsychological assessment of attention in adults with different subtypes of attention-deficit/hyperactivity disorder.

Authors:  L Tucha; O Tucha; R Laufkötter; S Walitza; H E Klein; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.